Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06433947
Title Study to Assess Safety and Tolerability of OPN-6602 in Subjects With Relapsed and/or Refractory Multiple Myeloma
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Opna Bio LLC
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
Banner MD Anderson RECRUITING Gilbert Arizona 85234 United States Details
Dana Farber Cancer Institute NOT_YET_RECRUITING Boston Massachusetts 02215 United States Details
Karmanos Cancer Institute RECRUITING Detroit Michigan 48201 United States Details
START Midwest RECRUITING Grand Rapids Michigan 49546 United States Details
Fred Hutchinson Cancer Center RECRUITING Seattle Washington 98109 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field